Tissue sealant compositions, vascular closure devices, and uses thereof
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61L-024/10
A61L-024/00
출원번호
US-0266161
(2010-04-27)
등록번호
US-9433700
(2016-09-06)
국제출원번호
PCT/US2010/032519
(2010-04-27)
§371/§102 date
20111025
(20111025)
국제공개번호
WO2010/129258
(2010-11-11)
발명자
/ 주소
Basore, Bob O.
Neumann, William L.
Dorshow, Richard B.
Rajagopalan, Raghavan
출원인 / 주소
MediBeacon Inc.
대리인 / 주소
Bennett, Dennis A.
인용정보
피인용 횟수 :
0인용 특허 :
90
초록▼
The present invention provides tissue sealant compositions and vasculature closure devices useful for the optical detection of tissue seal and/or clot formation. Compositions and devices of the present invention comprise optical dyes which undergo an observable change as the compositions and/or devi
The present invention provides tissue sealant compositions and vasculature closure devices useful for the optical detection of tissue seal and/or clot formation. Compositions and devices of the present invention comprise optical dyes which undergo an observable change as the compositions and/or devices are incorporated into a tissue seal and/or clot, for example a change in fluorescence quantum yield and/or a change in visual color including a change in emission and/or absorption wavelength. Tissue sealants and vasculature closure devices of the present invention are useful for visualizing seal and/or clot formation, for example, during or after surgical procedures, after catheter removal, etc. The present invention further provides methods for formation and optical detection of tissue seals or vasculature puncture closures as well as medical kits useful for the formation and optical detection of tissue seals or vasculature puncture closures.
대표청구항▼
1. A tissue sealant comprising: an adhesive material that is activated to form a seal when contacted with a biological tissue; andan optical dye noncovalently associated with the adhesive material; wherein the optical dye exhibits a first optical condition prior to activation of the adhesive materia
1. A tissue sealant comprising: an adhesive material that is activated to form a seal when contacted with a biological tissue; andan optical dye noncovalently associated with the adhesive material; wherein the optical dye exhibits a first optical condition prior to activation of the adhesive material and exhibits a second optical condition that is distinguishable from the first optical condition after activation of the adhesive material,wherein the first optical condition of the optical dye is a first fluorescence quantum yield prior to activation of the adhesive material and the second optical condition of the optical dye is a second fluorescence quantum yield after activation of the adhesive material, wherein the second fluorescence quantum yield is different from the first fluorescence quantum yield; wherein the first fluorescence quantum yield is substantially equal to 0 and the second fluorescence quantum yield is greater than or equal to 0.01, or wherein the second fluorescence quantum yield is greater than the first fluorescence quantum yield by at least a factor of 1.5 or is less than the first fluorescence quantum yield by at least a factor of 1.5,wherein activation of the adhesive material incorporates the optical dye into the tissue seal, fibrin network, or clot; immobilizes the optical dye in the tissue seal, fibrin network, or clot, or rigidifies the optical dye, thereby providing a change from the first optical condition to the second optical condition; andwherein activation of the adhesive material initiates a coagulation cascade in a subject. 2. The tissue sealant of claim 1, wherein activation of the adhesive material comprises formation of a tissue seal, a fibrin network, a synthetic polymer network or a clot. 3. The tissue sealant of claim 1, wherein the optical condition is absorbance, fluorescence, color, reflectance or an optoacoustic condition. 4. The tissue sealant of claim 1, wherein the first optical condition of the optical dye is a first emission wavelength or distribution of emission wavelengths prior to activation of the adhesive material and the second optical condition of the optical dye is a second emission wavelength or distribution of emission wavelengths after activation of the adhesive material, wherein the second emission wavelength or distribution of emission wavelengths is different from the first emission wavelength or distribution of emission wavelengths; wherein the second emission wavelength is greater than or less than the first emission wavelength by at least 20 nanometers, or wherein at least a portion of the second distribution of emission wavelengths is greater than or less than at least a portion of the first distribution of emission wavelengths by at least 20 nanometers. 5. The tissue sealant of claim 1, wherein the first optical condition of the optical dye is a first absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum prior to activation of the adhesive material and the second optical condition of the optical dye is a second absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum after activation of the adhesive material, wherein the second absorption wavelength is different from the first absorption wavelength; wherein the second absorption wavelength is greater than the first absorption wavelength by at least 20 nanometers, or wherein the second absorption wavelength is less than the first absorption wavelength by at least 20 nanometers. 6. The tissue sealant of claim 1, wherein the adhesive material comprises collagen, fibrin, fibrinogen, fibronectin, prothrombin, thrombin, thromboplastin, factor V, factor X, factor XIII, a coagulation factor, a platelet factor, a coagulation activator, a platelet activator, a vasoconstrictor, a fibrinolysis inhibitor, a crosslinker, a glycosaminoglycan, a polysaccharide, a biopolymer, a synthetic polymer, or a growth factor. 7. The tissue sealant of claim 1, wherein the adhesive material comprises a polycyanoacrylate or monomers thereof, a polyethylene glycol or monomers thereof, a succinimide-derivatized polyethylene glycol or monomers thereof, a thiol-derivatized polyethylene glycol or monomers thereof, a polyisocyanate or monomers thereof, a polyacrylate or monomers thereof, a polyamine or monomers thereof, a polyamide or monomers thereof, or a polyurethane or monomers thereof. 8. The tissue sealant of claim 1, wherein the optical dye comprises a group corresponding to a pyrazine, a thiazole, a phenylxanthene, a phenothiazine, a phenoselenazine, a cyanine, an indocyanine, a squaraine, a dipyrrolo pyrimidone, an anthraquinone, a tetracene, a quinoline, an acridine, an acridone, a phenanthridine, an azo dye, a rhodamine, a phenoxazine, an azulene, an azaazulene, a triphenyl methane dye, an indole, a benzoindole, an indocarbocyanine, a Nile Red dye, a thionin dye, an isosulfan blue dye, or a benzoindocarbocyanine. 9. The tissue sealant of claim 1, wherein the first optical condition is presence of a color and the second optical condition is absence of a color. 10. The tissue sealant of claim 1, wherein the first optical condition is absence of color and the second optical condition is presence of a color. 11. The tissue sealant of claim 1, wherein the optical dye is isosulfan blue. 12. The tissue sealant of claim 1, wherein the optical dye is indocyanine green. 13. The tissue sealant of claim 1, wherein the optical condition is color. 14. A tissue sealant comprising: an adhesive material that is activated to form a seal when contacted with a biological tissue; andan optical dye noncovalently associated with the adhesive material; wherein the optical dye exhibits a first optical condition prior to activation of the adhesive material and exhibits a second optical condition that is distinguishable from the first optical condition after activation of the adhesive material,wherein the first optical condition of the optical dye is a first fluorescence quantum yield prior to activation of the adhesive material and the second optical condition of the optical dye is a second fluorescence quantum yield after activation of the adhesive material, wherein the second fluorescence quantum yield is different from the first fluorescence quantum yield; wherein the first fluorescence quantum yield is substantially equal to 0 and the second fluorescence quantum yield is greater than or equal to 0.01, or wherein the second fluorescence quantum yield is greater than the first fluorescence quantum yield by at least a factor of 1.5 or is less than the first fluorescence quantum yield by at least a factor of 1.5,wherein activation of the adhesive material incorporates the optical dye into the tissue seal, fibrin network, or clot; immobilizes the optical dye in the tissue seal, fibrin network, or clot, or rigidifies the optical dye, thereby providing a change from the first optical condition to the second optical condition; andwherein the adhesive material comprises collagen, fibrin, fibrinogen, fibronectin, prothrombin, thrombin, thromboplastin, factor V, factor X, factor XIII, a coagulation factor, a platelet factor, a coagulation activator, a platelet activator, a vasoconstrictor, a fibrinolysis inhibitor, a crosslinker, a glycosaminoglycan, a polysaccharide, a biopolymer, a synthetic polymer, or a growth factor. 15. The tissue sealant of claim 14, wherein activation of the adhesive material initiates a coagulation cascade in a subject. 16. The tissue sealant of claim 14, wherein activation of the adhesive material comprises formation of a tissue seal, a fibrin network, a synthetic polymer network or a clot. 17. The tissue sealant of claim 14, wherein the optical condition is absorbance, fluorescence, color, reflectance or an optoacoustic condition. 18. The tissue sealant of claim 14, wherein the first optical condition of the optical dye is a first emission wavelength or distribution of emission wavelengths prior to activation of the adhesive material and the second optical condition of the optical dye is a second emission wavelength or distribution of emission wavelengths after activation of the adhesive material, wherein the second emission wavelength or distribution of emission wavelengths is different from the first emission wavelength or distribution of emission wavelengths; wherein the second emission wavelength is greater than or less than the first emission wavelength by at least 20 nanometers, or wherein at least a portion of the second distribution of emission wavelengths is greater than or less than at least a portion of the first distribution of emission wavelengths by at least 20 nanometers. 19. The tissue sealant of claim 14, wherein the first optical condition of the optical dye is a first absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum prior to activation of the adhesive material and the second optical condition of the optical dye is a second absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum after activation of the adhesive material, wherein the second absorption wavelength is different from the first absorption wavelength; wherein the second absorption wavelength is greater than the first absorption wavelength by at least 20 nanometers, or wherein the second absorption wavelength is less than the first absorption wavelength by at least 20 nanometers. 20. The tissue sealant of claim 14, wherein the optical dye comprises a group corresponding to a pyrazine, a thiazole, a phenylxanthene, a phenothiazine, a phenoselenazine, a cyanine, an indocyanine, a squaraine, a dipyrrolo pyrimidone, an anthraquinone, a tetracene, a quinoline, an acridine, an acridone, a phenanthridine, an azo dye, a rhodamine, a phenoxazine, an azulene, an azaazulene, a triphenyl methane dye, an indole, a benzoindole, an indocarbocyanine, a Nile Red dye, a thionin dye, an isosulfan blue dye, or a benzoindocarbocyanine. 21. The tissue sealant of claim 14, wherein the first optical condition is presence of a color and the second optical condition is absence of a color. 22. The tissue sealant of claim 14, wherein the first optical condition is absence of color and the second optical condition is presence of a color. 23. The tissue sealant of claim 14, wherein the optical dye is isosulfan blue. 24. The tissue sealant of claim 14, wherein the optical dye is indocyanine green. 25. The tissue sealant of claim 14, wherein the optical condition is color.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (90)
Weinstein Lawrence A. (Davie FL) Hillstead Richard A. (Duluth GA), Apparatus and method for delivering a vessel plug into the body of a patient.
Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
Cohn Daniel (Jerusalem ILX) Younes Hani (Ara-Meshulush ILX) Uretzky Gideon (Jerusalem ILX), Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical article.
Achilefu, Samuel; Jimenez, Hermo N.; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugai, Joseph E., Compounds as dynamic organ function monitoring agents.
Achilefu Samuel ; Dorshow Richard Bradley ; Bugaj Joseph Edward ; Rajagopalan Raghavan, Cyanine and indocyanine dye bioconjugates for biomedical applications.
Wilkinson Francis,GBX ; Mandley David John,GBX, Enhancement of activation for `biological` tissue adhesives, bonding agents and sealants using "color change" chromophores.
Nash John (Downingtown PA) Evans Douglas (Devon PA), Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and.
Achilefu, Samuel; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugaj, Joseph E.; Periasamy, Muthunadar P., Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients.
Achilefu, Samuel; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugaj, Joseph E., Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients.
Achilefu, Samuel; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugaj, Joseph E., Indole compounds as minimally invasive physiological function monitoring agents.
Achilefu, Samuel; Jimenez, Hermo N.; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugaj, Joseph E., Light sensitive compounds for instant determination of organ function.
Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Methods for tissue repair using adhesive materials.
Achilefu, Samuel I.; Rajagopalan, Raghavan; Dorshow, Richard B.; Bugaj, Joseph E.; Periasamy, Muthunadar P., Optical diagnostic and therapeutic agents and compositions.
Achilefu, Samuel; Dorshow, Richard B.; Rajagopalan, Raghavan; Bugaj, Joseph E., Pathological tissue detection and treatment employing targeted benzoindole optical agents.
Hubbell Jeffrey A. (Austin TX) Pathak Chandrashekhar P. (Waltham MA) Sawhney Amarpreet S. (Newton MA) Desai Neil P. (Los Angeles CA) Hill Jennifer L. (Austin TX), Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers.
Antanavich Richard D. (Paso Robles CA) Dorian Randel (Orinda CA), Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant.
Suggs Laura J. (Rice University ; 6100 Main St ; Houston TX 77005) Payne Richard G. (Rice University ; 6100 Main St ; Houston TX 77005) Yaszemski Michael J. (Lackland A.F.B. ; 59th Medical Wing/PSSB , Poly(propylene fumarate-co-ethylene oxide).
Nowinski Robert C. (King County WA) Hoffman Allan S. (King County WA), Polymerizable compounds and methods for preparing synthetic polymers that integrally contain polypeptides.
Cohn Daniel (Jerusalem ILX) Yitzchaiek Shlomo (Ramat Gan ILX) Bilenkis Sophie (Jerusalem ILX), Polyurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same.
Combs Arthur H. ; Dorshow Richard B. ; Bugaj Joseph E. ; Rajagopalan Raghavan ; Achilefu Samuel I., Simultaneous multimodal measurement of physiological function.
MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Hollinger,Jeffrey O.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas; Singh,Manish, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee,Martin James; Drohan,William Nash; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Fort Lee NJ) Eaton Alexander M. (Durham NC), Tissue bonding and sealing composition and method of using the same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.